News

Over 500 million people worldwide suffer from diabetes—a disease that contributes to major complications such as stroke, ...
Over 500 million people worldwide suffer from diabetes-a disease that contributes to major complications such as stroke, ...
Ekaterine Berishvili, a surgeon turned tissue engineer, is now focused on developing bioartificial pancreases. She has honed ...
The findings of a new study lend support for type 1 diabetes autoantibody screening in people with other autoimmune ...
Researchers receive funding for proof-of-principle experiments investigating potential of cell replacement therapies for ...
On a smoky Friday night in Humboldt, hundreds of patrons, twenty hardy runners, an organization of tireless volunteers, and ...
Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH02.06.2025 / 13:39 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The ...
The risk of major cardiac events was 50% higher in adult-onset type 1 diabetes than in population controls, and the risk of ...
TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy, ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is pleased to announce two exciting developments at the Breakthrough T1D Center of ...